Arcellx (ACLX) Prepaid Assets (2021 - 2025)
Arcellx (ACLX) recorded quarterly Prepaid Assets of $11.8 million in Q4 2025, up 10.76% quarter-over-quarter from $10.7 million in Q3 2025, and up 1.04% on a YoY basis from $11.7 million in Q4 2024.
Arcellx (ACLX) Prepaid Assets (2021 - 2025) Analysis & Trends
Arcellx's Prepaid Assets history runs 5 years deep, the most recent figure standing at $11.8 million for Q4 2025.
- In Q4 2025, Prepaid Assets rose 1.04% year-over-year to $11.8 million; the TTM figure through Dec 2025 stood at $11.8 million (up 1.04% YoY), while the FY2025 annual figure was $11.8 million, up 1.04% from the prior year.
- Prepaid Assets was $11.8 million for Q4 2025 at Arcellx, up from $10.7 million in the prior quarter.
- In the past five years, Prepaid Assets ranged from a high of $22.2 million in Q2 2023 to a low of $8.2 million in Q4 2021.
- Historically, Prepaid Assets has averaged $13.5 million across 5 years, with a median of $12.4 million in 2023.
- The sharpest annual moves came in 2023 and 2024: Prepaid Assets soared 112.73% in 2023, then tumbled 39.94% in 2024.
- A 5-year view of Prepaid Assets shows it stood at $8.2 million in 2021, then jumped by 46.83% to $12.0 million in 2022, then gained by 3.45% to $12.4 million in 2023, then decreased by 5.75% to $11.7 million in 2024, then advanced by 1.04% to $11.8 million in 2025.
- The last three Prepaid Assets figures came in at $11.8 million (Q4 2025), $10.7 million (Q3 2025), and $10.8 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Arcellx | 6.48 Bn | 6.48 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 11.85 Mn |
| Sep 30, 2025 | 10.70 Mn |
| Jun 30, 2025 | 10.79 Mn |
| Mar 31, 2025 | 10.68 Mn |
| Dec 31, 2024 | 11.73 Mn |
| Sep 30, 2024 | 12.84 Mn |
| Jun 30, 2024 | 13.31 Mn |
| Mar 31, 2024 | 14.61 Mn |
| Dec 31, 2023 | 12.44 Mn |
| Sep 30, 2023 | 20.26 Mn |
| Jun 30, 2023 | 22.16 Mn |
| Mar 31, 2023 | 16.54 Mn |
| Dec 31, 2022 | 12.03 Mn |
| Sep 30, 2022 | 9.52 Mn |
| Jun 30, 2022 | 18.10 Mn |
| Mar 31, 2022 | 13.46 Mn |
| Dec 31, 2021 | 8.19 Mn |